Correlation Between Taigen Biopharmaceutica and Sunmax Biotechnology

Can any of the company-specific risk be diversified away by investing in both Taigen Biopharmaceutica and Sunmax Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Taigen Biopharmaceutica and Sunmax Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Taigen Biopharmaceuticals Holdings and Sunmax Biotechnology Co, you can compare the effects of market volatilities on Taigen Biopharmaceutica and Sunmax Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Taigen Biopharmaceutica with a short position of Sunmax Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Taigen Biopharmaceutica and Sunmax Biotechnology.

Diversification Opportunities for Taigen Biopharmaceutica and Sunmax Biotechnology

-0.74

Correlation Coefficient

Taigen Biopharmaceutica  Sunmax Biotechnology

Pay attention - limited upside

The 3 months correlation between Taigen and Sunmax is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Taigen Biopharmaceuticals Hold and Sunmax Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunmax Biotechnology and Taigen Biopharmaceutica is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Taigen Biopharmaceuticals Holdings are associated (or correlated) with Sunmax Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunmax Biotechnology has no effect on the direction of Taigen Biopharmaceutica i.e., Taigen Biopharmaceutica and Sunmax Biotechnology go up and down completely randomly.

Pair Corralation between Taigen Biopharmaceutica and Sunmax Biotechnology

Assuming the 90 days trading horizon Taigen Biopharmaceuticals Holdings is expected to under-perform the Sunmax Biotechnology. In addition to that, Taigen Biopharmaceutica is 2.65 times more volatile than Sunmax Biotechnology Co. It trades about -0.08 of its total potential returns per unit of risk. Sunmax Biotechnology Co is currently generating about -0.08 per unit of volatility. If you would invest  28,500  in Sunmax Biotechnology Co on October 9, 2024 and sell it today you would lose (450.00) from holding Sunmax Biotechnology Co or give up 1.58% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Taigen Biopharmaceuticals Hold  vs.  Sunmax Biotechnology Co

Taigen Biopharmaceutica

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Taigen Biopharmaceuticals Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in February 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Sunmax Biotechnology

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Sunmax Biotechnology Co are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Sunmax Biotechnology may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with Taigen Biopharmaceutica and Sunmax Biotechnology

The main advantage of trading using opposite Taigen Biopharmaceutica and Sunmax Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Taigen Biopharmaceutica position performs unexpectedly, Sunmax Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunmax Biotechnology will offset losses from the drop in Sunmax Biotechnology's long position.

The idea behind Taigen Biopharmaceuticals Holdings and Sunmax Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.